How to ensure the safe,effective,and ethical use of emerging biotechnologies,such as clustered regularly interspaced short palindromic repeats(CRISPR)-based genome editing,is a global challenge.The occurrence of the&q...How to ensure the safe,effective,and ethical use of emerging biotechnologies,such as clustered regularly interspaced short palindromic repeats(CRISPR)-based genome editing,is a global challenge.The occurrence of the"CRISPR babies"in 2018 publicly brought this issue into sharp focus,and led to comprehensive regulatory reforms in China and various countries around the world.The current article analyzes this event-driven regulatory reform in China by elaborating the most salient provisions designed to prevent risk and protect individual rights,public health,and social morality relating to human genome editing in four important sectors of law:biosecurity law,civil code,criminal law and patent law.It highlights that,although regulation is being undertaken,the gaps between the law and advancing technology remain discernible,at both a national and transnational level(i.e.,the "double-pacing problem").Further attention and collaboration will be required to address the ongoing challenges associated with the use of human genome editing.展开更多
Formulated and endorsed by the international scientific community,the Tianjin Biosecurity Guidelines are a set of ten guiding principles and standards of conduct designed to promote responsible sciences and strengthen...Formulated and endorsed by the international scientific community,the Tianjin Biosecurity Guidelines are a set of ten guiding principles and standards of conduct designed to promote responsible sciences and strengthen biosecurity governance at national and institutional levels.It may be used to develop new or enhance,supplement,and update the existing codes of conduct adaptive to a specific context and responsive to the bio-risks arising from the rapid advances in biological sciences.展开更多
How to address the impact of genome editing on human rights is a global challenge.The World Health Organization(WHO)recently developed a governance framework for human genome editing to provide global recommendations ...How to address the impact of genome editing on human rights is a global challenge.The World Health Organization(WHO)recently developed a governance framework for human genome editing to provide global recommendations for establishing appropriate governance mechanisms for human genome editing.This article suggests that a human rights-respecting approach should be explicitly recognized in the framework and other relevant endeavors.Such recognition has significant implications not only on clarifying the duty of States but also on the responsibility of non-State actors,particularly biotech enterprises,to orient this technology towards respect for human rights.To implement this approach,the United Nations Guiding Principles on Business and Human Rights(UNGPs)provide helpful guidance for States,biotech enterprises,and other stakeholders to raise awareness and enhance responsible practices in the field.展开更多
基金This research was supported by grants from the National Key Research and Development Program of China(Grant nos.2019YFA0904600 and 2020YFA0908600).
文摘How to ensure the safe,effective,and ethical use of emerging biotechnologies,such as clustered regularly interspaced short palindromic repeats(CRISPR)-based genome editing,is a global challenge.The occurrence of the"CRISPR babies"in 2018 publicly brought this issue into sharp focus,and led to comprehensive regulatory reforms in China and various countries around the world.The current article analyzes this event-driven regulatory reform in China by elaborating the most salient provisions designed to prevent risk and protect individual rights,public health,and social morality relating to human genome editing in four important sectors of law:biosecurity law,civil code,criminal law and patent law.It highlights that,although regulation is being undertaken,the gaps between the law and advancing technology remain discernible,at both a national and transnational level(i.e.,the "double-pacing problem").Further attention and collaboration will be required to address the ongoing challenges associated with the use of human genome editing.
基金supported by grants from the National Key Research and Development Program of China(Grant nos.2019YFA0904600 and 2020YFA0908600).
文摘Formulated and endorsed by the international scientific community,the Tianjin Biosecurity Guidelines are a set of ten guiding principles and standards of conduct designed to promote responsible sciences and strengthen biosecurity governance at national and institutional levels.It may be used to develop new or enhance,supplement,and update the existing codes of conduct adaptive to a specific context and responsive to the bio-risks arising from the rapid advances in biological sciences.
基金supported by grants from the National Key Research and Development Program of China(Grant nos.2019YFA0904600 and 2020YFA0908600).
文摘How to address the impact of genome editing on human rights is a global challenge.The World Health Organization(WHO)recently developed a governance framework for human genome editing to provide global recommendations for establishing appropriate governance mechanisms for human genome editing.This article suggests that a human rights-respecting approach should be explicitly recognized in the framework and other relevant endeavors.Such recognition has significant implications not only on clarifying the duty of States but also on the responsibility of non-State actors,particularly biotech enterprises,to orient this technology towards respect for human rights.To implement this approach,the United Nations Guiding Principles on Business and Human Rights(UNGPs)provide helpful guidance for States,biotech enterprises,and other stakeholders to raise awareness and enhance responsible practices in the field.
